Insider buying
~$1.2K1,000 sh @ $1.16
Traded Sep 22, 2025 · filed 220 days later
The CFO of Estrella Immunopharma paid $1.2K out of pocket for Estrella Immunopharma shares. Shares held went up 6% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 11, 2025 · Filed Apr 30, 2026
The CFO of Estrella Immunopharma paid $104 out of pocket for Estrella Immunopharma shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$104
Shares × reported transaction price
<$25K
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded 11 days before ESLA filed an 8-K: changed a top executive or board member (Sep 22, 2025). The first open-market purchase by any ESLA insider since Mar 2022
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −22.6% | +1.8% | −24.4% |
| 30 days | −31.7% | +5.5% | −37.3% |
| 90 days | −52.5% | +1.5% | −54.0% |
| 180 days | −43.1% | +7.1% | −50.3% |
Past results only. Not a forecast.
Insider buying
Traded Sep 22, 2025 · filed 220 days later
The CFO of Estrella Immunopharma paid $1.2K out of pocket for Estrella Immunopharma shares. Shares held went up 6% with this purchase.
Insider buying
Traded Oct 7, 2025 · filed 205 days later
The CFO of Estrella Immunopharma paid $1.3K out of pocket for Estrella Immunopharma shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.